|
TRMT6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.919400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.561100E-03 |
| Normal-vs-Stage2 |
2.280000E-02 |
| Normal-vs-Stage3 |
1.719600E-02 |
| Normal-vs-Stage4 |
5.483200E-03 |
| Stage1-vs-Stage2 |
9.761800E-01 |
| Stage1-vs-Stage3 |
7.969200E-01 |
| Stage1-vs-Stage4 |
4.551400E-01 |
| Stage2-vs-Stage3 |
8.524200E-01 |
| Stage2-vs-Stage4 |
6.158200E-01 |
| Stage3-vs-Stage4 |
4.368000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.196700E-03 |
| Normal-vs-AfricanAmerican |
2.759800E-01 |
| Normal-vs-Asian |
3.805600E-02 |
| Caucasian-vs-AfricanAmerican |
3.150600E-01 |
| Caucasian-vs-Asian |
5.515000E-01 |
| AfricanAmerican-vs-Asian |
6.009800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.48269999999695E-05 |
| Normal-vs-Female |
1.580150E-02 |
| Male-vs-Female |
1.138380E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.341200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.173800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.755600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.035000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.783600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.320600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.162000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.769200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.798600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.752600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.927400E-01 |
| Classical-VS-Follicular |
1.060810E-01 |
| Classical-VS-Other |
4.410400E-02 |
| Classical-VS-Normal |
1.848290E-02 |
| Tall-VS-Follicular |
4.514600E-01 |
| Tall-VS-Other |
8.316000E-02 |
| Tall-VS-Normal |
6.988100E-02 |
| Follicular-VS-Other |
2.990600E-01 |
| Follicular-VS-Normal |
2.197900E-03 |
| Other-VS-Normal |
3.641800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.386400E-04 |
| Normal-vs-N1 |
1.172350E-02 |
| N0-vs-N1 |
8.351600E-01 |
|
|
